|
|
|
MIRA INFORM REPORT
|
Report No. : |
494135 |
|
Report Date : |
26.02.2018 |
IDENTIFICATION DETAILS
|
Name : |
ENALTEC LABS PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
1706, 17th Floor, Kesar Solitaire, Plot No.5, Sector – 19, Sanpada,
Navi Mumbai 400705, Maharashtra |
|
Tel. No.: |
91-22-67507000 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of
Incorporation : |
24.02.2006 |
|
|
|
|
Com. Reg. No.: |
11-160020 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
INR 15.477 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U73100MH2006PTC160020 |
|
|
|
|
IEC No.: [Import-Export
Code No.] |
0306048906 |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
Not Available |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCE5821H |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is engaged in the business of Research and Development manufacturers, refiners, importers, exporters, traders, Packers, developers of technologies for all types of pharmaceutical ingredients and intermediaries. medicines and medical preparations medicinal drugs, bulk drugs, Formulations, laboratory raw materials and bio-chemicals, etc. [Registered Activity] |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A+ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
Maximum Credit Limit : |
USD 2900000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject was incorporated on 24th February 2016. The company
is engaged in the activity of Research and Development and sale of
pharmaceutical products. For the financial year ended 2017, the company has reported dip in its
revenue by 4.20% as compared to previous year revenue but has managed to
maintain an average profit margin of 1.47%. The company’s sound financial profile is reflects by its sound net worth
base along with above average solvency indicators due to low debt balance
sheet profile and average liquidity position. However, rating strength is partially offset by vulnerability of its
operating margins to volatility in raw material prices and working capital
intensive operations. Payments seems to be regular. In view of aforesaid, the company can be considered for business
dealings at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 26.02.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
LOCATIONS
|
Registered Office /
Corporate Office: |
1706, 17th Floor, Kesar Solitaire, Plot No.5, Sector – 19,
Sanpada, Navi Mumbai 400705, Maharashtra, India |
|
Tel. No.: |
91-22-41707000 / 67507000 |
|
Fax No.: |
91-22-41707070 |
|
E-Mail : |
|
|
Website : |
|
|
Location: |
Rented |
|
Locality: |
Commercial |
|
|
|
|
MANUFACTURING UNITS |
|
|
Factory 1 : |
Plot No. N-61, MIDC, Additional Ambernath, District Thane, Mumbai –
421506, Maharashtra, India |
|
|
|
|
Factory 2 : |
Gat No.204, Nashik-Mumbai Highway, Vadicarhe, Taluka Igatpuri,
District Nashik – 422403, Maharashtra, India
|
|
|
|
|
RESEARCH LABS |
|
|
|
|
|
Research Lab (API):
|
W–59 A, Additional Ambernath Industrial Area, Anand Nagar, Ambernath
(East), Mumbai – 421506, Maharashtra, India |
|
|
|
|
Formulation Lab 1: |
Plot No. W-18, Anand Nagar MIDC, Addl. Ambernath, MIDC, District – Thane – 421 506, Maharashtra, India |
|
|
|
|
Formulation Lab 2: |
Plot No. PL-11, Anand Nagar MIDC, Addl. Ambernath, MIDC, District – Thane – 421 506, Maharashtra, India |
DIRECTORS
AS ON 31.03.2017
|
Name : |
Mr. Anand Prafulchandra Shah |
||||||||||||||||
|
Designation : |
Managing Director |
||||||||||||||||
|
Address : |
1704, Kesar Solitaire, Plot No. 5, Sector 19, Sanpada,
Navi Mumbai - 400705, Maharashtra, India |
||||||||||||||||
|
Date of Birth/Age : |
09.03.1973 |
||||||||||||||||
|
Qualification : |
BE and MBA |
||||||||||||||||
|
Date of Appointment : |
11.11.2008 |
||||||||||||||||
|
DIN No.: |
00597145 |
||||||||||||||||
|
PAN No.: |
AECPS5670J |
||||||||||||||||
|
Other directorship:
|
|||||||||||||||||
|
|
|
||||||||||||||||
|
Name : |
Mr. Susheel Koul |
||||||||||||||||
|
Designation : |
Director |
||||||||||||||||
|
Address : |
1601, Bloomingdale, 16th Floor, Hiranandani Estate, GB
Road, Thane - 400607, Maharashtra, India |
||||||||||||||||
|
Date of Birth/Age : |
01.05.1965 |
||||||||||||||||
|
Qualification : |
B.Sc., BA and DMM |
||||||||||||||||
|
Date of Appointment : |
11.11.2008 |
||||||||||||||||
|
DIN No.: |
00925887 |
||||||||||||||||
|
PAN No.: |
AEZPK8099J |
||||||||||||||||
|
Other directorship:
|
|||||||||||||||||
|
|
|
||||||||||||||||
|
Name : |
Mr. Sumit Gupta |
||||||||||||||||
|
Designation : |
Nominee Director |
||||||||||||||||
|
Address : |
B-3, Second Floor, East of Kailash, New Delhi -110065,
India |
||||||||||||||||
|
Date of Appointment : |
27.03.2017 |
||||||||||||||||
|
DIN No.: |
06401402 |
||||||||||||||||
|
Other directorship:
|
|||||||||||||||||
MAJOR SHAREHOLDERS
AS ON 31.03.2017
|
Names of Shareholders |
|
No. of Shares |
|
Indian Life Sciences Fund II, LLC, Mauritius |
|
863016 |
|
Anand Prafulchandra Shah S/O Prafulchandra Mangaldas Shah |
|
185718 |
|
Susheel Koul S/o Jawahar Lal Koul |
|
185718 |
|
Genlink Pharma Solutions Private Limited, India |
|
563497 |
|
Total |
|
1797949 |
Equity Share Break up (Percentage of Total Equity)
AS ON 23.08.2017
|
Category |
Percentage |
|
Promoters- Individual/Hindu Undivided Family- Indian |
20.66 |
|
Promoters- Body corporate |
79.34 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged in the business of Research and Development manufacturers, refiners, importers, exporters, traders, Packers, developers of technologies for all types of pharmaceutical ingredients and intermediaries. medicines and medical preparations medicinal drugs, bulk drugs, Formulations, laboratory raw materials and bio-chemicals, etc. [Registered Activity] |
||||
|
|
|
||||
|
Products / Services
: |
|
||||
|
|
|
||||
|
Brand Names : |
Not Available |
||||
|
|
|
||||
|
Agencies Held : |
Not Available |
||||
|
|
|
||||
|
Exports : |
Not Available |
||||
|
|
|
||||
|
Imports : |
Not Available |
||||
|
|
|
||||
|
Terms : |
Not Available |
PRODUCTION STATUS – (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Not Available |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
(INR
In Million)
|
|
Auditors : |
|
|
Name : |
Shankarlal Jain and Associates LLP Chartered Accountants |
|
Address : |
12 Engineer Building, 2nd Flat, 265 Princess Street, Above Parsi Dairy, Mumbai – 400002, Maharashtra, India |
|
PAN N Income-tax PAN of auditor or auditor's firm : |
AACFS6967Q |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Subsidiaries : |
|
CAPITAL STRUCTURE
AS ON 31.03.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
2200000 |
Equity Shares |
INR 10/- each |
INR 22.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
1797949 |
Equity Shares |
INR 10/- each |
INR 17.979 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
17.979 |
15.476 |
15.476 |
|
(b) Reserves and Surplus |
988.675 |
639.468 |
571.652 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
1006.654 |
654.944 |
587.128 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
78.521 |
42.245 |
49.511 |
|
(b) Deferred tax liabilities (Net) |
12.190 |
2.648 |
5.138 |
|
(c) Other long-term
liabilities |
0.000 |
3.080 |
11.320 |
|
(d) long-term
provisions |
10.564 |
8.770 |
6.852 |
|
Total Non-current
Liabilities (3) |
101.275 |
56.743 |
72.821 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short-term
borrowings |
230.916 |
236.961 |
203.777 |
|
(b) Trade
payables |
503.801 |
379.721 |
337.471 |
|
(c) Other current
liabilities |
103.614 |
141.393 |
164.669 |
|
(d) Short-term
provisions |
1.441 |
11.650 |
33.306 |
|
Total Current
Liabilities (4) |
839.772 |
769.725 |
739.223 |
|
|
|
|
|
|
TOTAL |
1947.701 |
1481.412 |
1399.172 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
336.469 |
338.713 |
318.581 |
|
(ii)
Intangible Assets |
106.174 |
98.690 |
92.669 |
|
(iii) Tangible assets
capital work-in-progress |
65.547 |
3.078 |
0.000 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
19.964 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d)
Long-term loans and advances |
30.996 |
37.365 |
37.270 |
|
(e) Other Non-current
assets |
0.000 |
0.000 |
0.000 |
|
Total Non-Current
Assets |
559.150 |
477.846 |
448.520 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
357.020 |
269.709 |
329.096 |
|
(c) Trade
receivables |
464.771 |
510.334 |
512.599 |
|
(d) Cash and
bank balances |
304.710 |
27.283 |
28.722 |
|
(e)
Short-term loans and advances |
176.909 |
116.402 |
65.178 |
|
(f) Other
current assets |
85.141 |
79.838 |
15.057 |
|
Total
Current Assets |
1388.551 |
1003.566 |
950.652 |
|
|
|
|
|
|
TOTAL |
1947.701 |
1481.412 |
1399.172 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SALES |
|
|
|
|
|
Income |
1652.002 |
1724.445 |
1687.502 |
|
|
Other Income |
24.050 |
2.671 |
10.158 |
|
|
TOTAL |
1676.052 |
1727.116 |
1697.660 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials
Consumed |
743.018 |
728.366 |
910.685 |
|
|
Purchases of
Stock-in-Trade |
130.398 |
85.495 |
77.854 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
(26.451) |
62.657 |
(48.032) |
|
|
Employee benefit expense |
188.973 |
139.958 |
81.124 |
|
|
CSR expenditure |
0.200 |
0.000 |
1.809 |
|
|
Other expenses |
520.557 |
562.891 |
374.259 |
|
|
TOTAL |
1556.695 |
1579.367 |
1397.699 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
119.357 |
147.749 |
299.961 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
30.900 |
24.934 |
32.999 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
88.457 |
122.815 |
266.962 |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
44.013 |
40.758 |
32.304 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
BEFORE TAX |
44.444 |
82.057 |
234.658 |
|
|
|
|
|
|
|
Less |
TAX |
20.235 |
14.241 |
56.639 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX |
24.209 |
67.816 |
178.019 |
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
NA |
NA |
933.897 |
|
|
TOTAL EARNINGS |
NA |
NA |
933.897 |
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
Raw Materials |
NA |
NA |
489.448 |
|
|
TOTAL IMPORTS |
NA |
NA |
489.448 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
13.47 |
43.82 |
115.03 |
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
3.573 |
7.500 |
7.572 |
|
|
|
|
|
|
Cash generated from operations |
NA |
NA |
NA |
|
|
|
|
|
|
Net cash flows from (used in) operations |
103.277 |
123.156 |
209.507 |
|
|
|
|
|
|
Net cash flows from (used in) operating activities |
84.120 |
87.489 |
167.063 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry
Debtors / Income * 365 Days) |
102.69 |
108.02 |
110.87 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
3.55 |
3.38 |
3.29 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
210.54 |
170.30 |
124.61 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
0.33 |
0.55 |
0.91 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
0.23 |
0.34 |
0.73 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.47 |
0.55 |
0.57 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
0.31 |
0.44 |
0.44 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
0.83 |
1.18 |
1.26 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
0.50 |
0.67 |
0.70 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
3.86 |
5.93 |
9.09 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) * 100) |
% |
1.47 |
3.93 |
10.55 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
1.24 |
4.58 |
12.72 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
2.40 |
10.35 |
30.32 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current
Assets / Current Liabilities) |
1.65 |
1.30 |
1.29 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
1.23 |
0.95 |
0.84 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.52 |
0.44 |
0.42 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
17.41 |
18.53 |
16.86 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
1.65 |
1.30 |
1.29 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Share Capital |
15.476 |
15.476 |
17.979 |
|
Reserves & Surplus |
571.652 |
639.468 |
988.675 |
|
Money received against share
warrants |
0.000 |
0.000 |
0.000 |
|
Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Net
worth |
587.128 |
654.944 |
1006.654 |
|
|
|
|
|
|
Long-term borrowings |
49.511 |
42.245 |
78.521 |
|
Short term borrowings |
203.777 |
236.961 |
230.916 |
|
Current maturities of
long-term debts |
7.572 |
7.500 |
3.573 |
|
Total
borrowings |
260.860 |
286.706 |
313.010 |
|
Debt/Equity
ratio |
0.444 |
0.438 |
0.311 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
1687.502 |
1724.445 |
1652.002 |
|
|
|
2.189 |
(4.201) |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
1687.502 |
1724.445 |
1652.002 |
|
Profit/ (Loss) |
178.019 |
67.816 |
24.209 |
|
|
10.55
% |
3.93
% |
1.47
% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
No |
|
8 |
Designation of contact person |
No |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
No |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
OPERATIONS:
The Company continues to be engaged in the activity of sale of pharmaceutical products and research and development in pharma
INDEX OF CHARGE:
|
SNO |
SRN |
CHARGE ID |
CHARGE HOLDER NAME |
DATE OF CREATION |
DATE OF MODIFICATION |
DATE OF SATISFACTION |
AMOUNT |
ADDRESS |
|
1 |
G47203526 |
100106316 |
HDFC BANK LIMITED |
28/04/2017 |
- |
- |
2119500.0 |
HDFC BANK HOUSE,
SENAPATI BAPAT MARG,LOWER PAREL (WEST)MUMBAIMH400013IN |
|
2 |
G47204169 |
100106318 |
HDFC BANK LIMITED |
28/04/2017 |
- |
- |
2119500.0 |
HDFC BANK HOUSE,
SENAPATI BAPAT MARG,LOWER PAREL (WEST)MUMBAIMH400013IN |
|
3 |
G52615994 |
100071385 |
AXIS BANK LIMITED |
02/01/2017 |
16/08/2017 |
- |
667700000.0 |
DHIRAJ BAUGH, NEAR
HARI NIWAS CIRCLE, THANETHANEMH400602IN |
|
4 |
G51807030 |
10490646 |
UNION BANK OF
INDIA LIMITED |
24/03/2014 |
07/08/2017 |
- |
667700000.0 |
MAYANI MANOR,SIR
M.V. ROADANDHERI- EASTMUMBAIMH400069IN |
|
5 |
C78547841 |
10348816 |
CHOLAMANDALAM
INVESTMENT AND FINANCE COMPANY LIMITED |
22/11/2011 |
- |
20/01/2016 |
464000.0 |
DARE HOUSENO. 2 N
S C BOSE ROAD, PARRYSCHENNAITN600001IN |
|
6 |
C16469561 |
10388644 |
STATE BANK OF
MAURITIUS LIMITED |
16/10/2012 |
15/05/2013 |
13/08/2014 |
60000000.0 |
101, RAHEJA
CENTRE, FREE PRESS JOURNAL ROAD,NARIMAN POINTMUMBAIMH400021IN |
|
7 |
C16424749 |
10394989 |
STATE BANK OF
MAURITIUS LIMITED |
21/12/2012 |
15/05/2013 |
13/08/2014 |
12500000.0 |
101, RAHEJA
CENTRE, FREE PRESS JOURNAL ROAD,NARIMAN POINTMUMBAIMH400021IN |
|
8 |
C05344403 |
10261385 |
ICICI BANK LIMITED |
11/01/2011 |
15/05/2013 |
13/05/2014 |
247575000.0 |
LANDMARKRACE
COURCE CIRCLEALKAPURIBARODAGJ390015IN |
|
9 |
B05552344 |
10199324 |
CENTRAL BANK OF
INDIA |
17/12/2009 |
- |
02/02/2011 |
140000000.0 |
1ST FLOOR, BAJAJ
BHAVANNARIMAN POINT, MUMBAI-400021MUMBAIMH400021IN |
|
10 |
B05080635 |
10170213 |
STATE BANK OF
INDIA |
31/07/2008 |
- |
29/01/2011 |
95000000.0 |
KONKAN BHAVAN
BRANCHCIDCO BHAVAN (SOUTH WING), CBD BELAPURNAVI MUMBAIMH400614IN |
FIXED ASSETS:
Tangible assets
- Land
- Buildings
- Plant and equipment
- Furniture and fixtures
- Vehicles
- Computer equipments
Intangible assets
- Computer software
- Patents
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 64.82 |
|
|
1 |
INR 90.40 |
|
Euro |
1 |
INR 79.76 |
INFORMATION DETAILS
|
Analysis Done by
: |
PRY |
|
|
|
|
Report Prepared
by : |
KVT |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.